Ionic Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,500
Closed -$319K 178
2023
Q4
$331K Buy
+11,500
New +$348K 0.08% 104
2023
Q1
Sell
-17,026
Closed -$872K 377
2022
Q4
$872K Buy
17,026
+2,530
+17% +$121K 0.21% 105
2022
Q3
$634K Buy
+14,496
New +$704K 0.09% 201
2018
Q2
Sell
-12,226
Closed -$412K 263
2018
Q1
$412K Sell
12,226
-1,054
-8% -$36.2K 0.03% 213
2017
Q4
$456K Sell
13,280
-41,528
-76% -$1.42M 0.02% 285
2017
Q3
$1.86M Buy
54,808
+46,258
+541% +$1.49M 0.07% 180
2017
Q2
$272K Sell
8,550
-1,041
-11% -$32.8K 0.01% 271
2017
Q1
$311K Sell
9,591
-76,521
-89% -$2.41M 0.02% 265
2016
Q4
$2.65M Buy
+86,112
New +$2.63M 0.14% 166
2016
Q3
Sell
-6,759
Closed -$226K 402
2016
Q2
$226K Buy
+6,759
New +$216K 0.01% 271
2016
Q1
Sell
-9,454
Closed -$270K 342
2015
Q4
$290K Sell
9,454
-132,783
-93% -$4.18M 0.02% 263
2015
Q3
$4.24M Buy
142,237
+62,660
+79% +$2.01M 0.23% 96
2015
Q2
$2.53M Buy
+79,577
New +$2.59M 0.12% 134
2014
Q3
Sell
-54,913
Closed -$1.55M 251
2014
Q2
$1.55M Buy
+54,913
New +$1.57M 0.05% 159
2013
Q3
Sell
-63,240
Closed -$1.68M 270
2013
Q2
$1.68M Buy
+63,240
New +$1.75M 0.05% 198

Other funds holding PFE

Ionic Capital Management's PFE Position: Q1 2024 in Review

Ionic Capital Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 11,500 shares — an estimated $319K sold.

Ionic Capital Management first reported a position in PFE in Q2 2013 and held it in 15 quarters. The position peaked at $4.24M in Q3 2015. 2,882 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Ionic Capital Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • Ionic Capital Management sold 11,500 Pfizer shares in Q1 2024, an estimated $319K.
  • Ionic Capital Management first reported a position in Pfizer in Q2 2013 and held it in 15 quarters.
  • Ionic Capital Management's Pfizer position peaked at $4.24M in Q3 2015.
  • 2,882 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Ionic Capital Management's 13F filing for Q1 2024, filed 15 May 2024.